Detalles de la búsqueda
1.
Establishment and Fractionation of Metastatic Axillary Lymph Node Cell Suspension for Determination of Protein Expression Levels of Nuclear cFOS and Cytosolic TGFß1 from Breast Cancer Patients.
Biol Proced Online;
24(1): 6, 2022 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658894
2.
Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases.
Int J Mol Sci;
22(4)2021 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33562134
3.
The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia.
Arch Virol;
161(5): 1189-98, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26860912
4.
Trefoil factor 1 in early breast carcinoma: a potential indicator of clinical outcome during the first 3 years of follow-up.
Int J Med Sci;
11(7): 663-73, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24843314
5.
Can granulysin provide prognostic value in primary breast cancer?
Pathol Res Pract;
237: 154039, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35905663
6.
Dual function miR-205 is positively associated with ER and negatively with five-year survival in breast cancer patients.
Pathol Res Pract;
238: 154080, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35994808
7.
Safety improving by complementary serological and molecular testing combined with pathogen reduction of the donated blood in window period.
Transfus Apher Sci;
49(1): 103-4, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23820432
8.
Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters.
Med Oncol;
35(2): 17, 2018 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29340905
9.
Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer.
J Cancer Res Clin Oncol;
133(8): 571-9, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17457609
10.
MiR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis.
Cancer Biomark;
16(3): 385-94, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26889816
11.
Case with triple-negative breast cancer shows overexpression of both cFOS and TGF-ß1 in node-positive tissue.
Per Med;
13(6): 523-530, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29754549
12.
Skewed X-chromosome inactivation in women affected by Alzheimer's disease.
J Alzheimers Dis;
43(4): 1251-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25159673
13.
Erythrocytotoxicity of tiazofurin in vivo and in vitro detected by scanning probe microscopy.
Toxicol Lett;
146(3): 275-84, 2004 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-14687765
14.
The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion.
Med Oncol;
31(3): 867, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24488617
15.
Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia.
Med Oncol;
31(6): 977, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24781337
16.
Cathepsin D as an indicator of clinical outcome in early breast carcinoma during the first 3 years of follow-up.
Biomark Med;
7(5): 747-58, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24044567
17.
Potential clinical significance of ERß ON promoter methylation in sporadic breast cancer.
Med Oncol;
30(3): 642, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23794253
18.
p14(ARF) methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma.
Med Oncol;
30(3): 682, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23918242
19.
Instability in X chromosome inactivation patterns in AMD: a new risk factor?
Med Hypothesis Discov Innov Ophthalmol;
2(3): 74-82, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24600647
20.
Different associations of estrogen receptor ß isoforms, ERß1 and ERß2, expression levels with tumor size and survival in early- and late-onset breast cancer.
Cancer Lett;
321(1): 73-9, 2012 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22366496